Clinical trial
Bladder Cancer Prognosis Programme (Incorporating SELENIB Trial)
NCT00553124 is registered in ClinicalTrials.gov with University Hospital Birmingham as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Bladder Cancer Prognosis Programme (Incorporating SELENIB Trial)
- Lead sponsor
- University Hospital Birmingham
- Phase
- Phase 3
- Overall status
- Unknown status
- Start date
- December 31, 2005
- Completion date
- Not reported
- Enrollment
- 3,400
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
bladder cancer